New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ofev (nintedanib) - Drug Insight and Market Forecast - 2030" - https ...
Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "OFEV Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report provides insights into OFEV for ...
The medication is used to treat adults with certain lung diseases. This approval represents a significant advancement in DifGen's expanding portfolio of complex generics and underscores the company's ...
RIDGEFIELD, Conn. and INGELHEIM, Germany, July 25, 2023 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug ...
Drug Commonly Used to Treat Rare Lung Condition May Improve Survival in Patients With Bladder Cancer
Treatment with a combination of Ofev and chemotherapy was shown to have a survival benefit in a group of patients with bladder cancer. Although treatment with Ofev (nintedanib) —a targeted inhibitor ...
(Reuters) - The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim's Ofev capsules for a rare lung disorder. The drug is first FDA-approved treatment for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results